EBOS Group (EBO) Stock Price, Fundamentals & Analysis

What EBO does

EBOS Group (EBO) is a stock listed on the ASX in the Healthcare sector, specifically the Medical Distribution industry. The company markets, wholesales, and distributes healthcare, medical, pharmaceutical, and animal care products across Australia, Southeast Asia, and New Zealand. It operates through two segments: Healthcare and Animal Care. Services range from healthcare logistics and medication management solutions to pharmacy management software, clinical trial logistics, and community-based health care programs. The company also supplies surgical devices, medical consumables, aesthetic healthcare devices, and animal health products such as dog and cat food and treats.

Key numbers explained

• 15.58 AUD is the current share price, the amount you would pay for one share on the market today.
• The trailing P/E ratio of 14.6 shows how much investors pay per dollar of the company's last 12 months of earnings; a lower number can suggest a cheaper valuation relative to earnings.
• The forward P/E ratio of 11.8 uses expected future earnings, which can be more relevant for growth expectations than the trailing figure.
• 1.07 AUD is the earnings per share (EPS) for the trailing 12 months, representing the portion of profit allocated to each share.
• The dividend yield of 5.52% indicates the annual dividend payment as a percentage of the current share price, a measure of income return.
• The ex-dividend date of Aug 27, 2026 is the cutoff: you must own the stock before this date to receive the next dividend.
• 79% of earnings are paid out as dividends, a high payout ratio that shows most profit is returned to shareholders.
• 0.15 is the beta, a measure of volatility relative to the market; a beta below 1 suggests the stock tends to move less than the overall market.

What to watch

• The price change over the last 52 weeks of -40.1% shows a significant decline from the year-ago level, which can reflect sector or market-wide pressures.
• The debt-to-equity ratio of 70 indicates the company uses a mix of debt and equity financing; higher ratios can signal more financial leverage.
• The profit margin of 1.7% and operating margin of 2.9% are relatively thin, typical for a distribution business with high revenue but low margins.
• The price-to-book ratio of 1.17 suggests the market values the company close to its book value, with little premium or discount.
• As a Healthcare sector stock, EBO can be influenced by regulatory changes, pharmaceutical pricing policies, and shifts in medical distribution demand. It is part of the broader Australian healthcare landscape alongside peers such as Sigma Healthcare (SIG) and Cochlear (COH).